A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin

It would also likely regulate how much insurance companies and pharmacy benefit managers can charge for insulin. **Who it affects:** - People with diabetes who use insulin (about 7-8 million Americans) - Their families who help pay for medications - Insurance companies and pharmacies **What would change:** - Patients would pay less for insulin each month - Insurance plans would face limits on what they can charge patients for insulin - People might be less likely to ration insulin due to cost, which can be dangerous **Current status:** The bill is still being reviewed in a Senate committee and has not been voted on yet. The goal is to address the significant financial burden insulin costs place on diabetic patients who need this life-saving medication.